Influence of dexrazoxane on epirubicin cytotoxicity in human breast cancer cell lines

高丽,李文凤,梁军,姚如永

DOI: https://doi.org/10.16073/j.cnki.cjcpt.2013.12.009

2013-01-01

Abstract:OBJECTIVE: To investigate the influence of epirubicin(EPI) cytotoxicity by dexrazoxane(DEX) in human breast cancer cell lines. METHODS: EPI of different concentrations was added into the culture fluid of human breast cancer cells. MTT method was used to detect the inhibition rate. Three breast cancer cell lines were treated with EPI(1.0 μg/mL), DEX(1.0, 10 and 20 μg/mL), or with EPI: DEX (1:1, 1:10, 1:20). MTT method was used to detect the inhibition rate. Flow cytometry was used to detect the apoptosis of the cells. RESULTS: The inhibition rates of group A(1.0 μg/mL EPI) were (48.72±0.34)%, (64.40±2.63)% and (58.57±2.23)% respectively. The inhibition rates of group E (1.0 μg/mL EPI+1.0 μg/mL DEX) were (46.44±1.35)%, (65.20±0.21)% and (57.52±2.31)% respectively. The inhibition rates of group F (1.0 μg/mL EPI+10 μg/mL DEX) were (47.57±2.20)%, (61.70±1.08)% and (59.54±1.26)% respectively. The inhibition rates of group G (1.0 μg/mL EPI+20 μg/mL DEX) were (43.85±1.19)%, (60.80±0.62)% and (58.25±3.50)% respectively. The apoptosis rates of group c(1.0 μg/mL EPI) were 8.54%, 11.25% and 10.78%, while the apoptosis rates of group d(1.0 μg/mL EPI+10 μg/mL DEX) were 8.74%, 11.85% and 10.49%. Compared with the inhibition rate of 1.0 μg/mL EPI, the inhibition rates of 1.0 μg/mL EPI combined with DEX(1.0, 10 μg/mL) showed no statistical difference (P>0.05). While the 1.0 μg/mL EPI combined with 20 μg/mL DEX had significant influence on the proliferation of breast cancer cells (P<0.05). CONCLUSION: DEX given at cardioprotective doses does not alter the cytotoxicity efficacy of the EPI.